Cargando…

A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies

Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction pow...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiunan, Wang, Hao, Ramazi, Pouria, Nah, Kyeongah, Lewis, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991680/
https://www.ncbi.nlm.nih.gov/pubmed/35394257
http://dx.doi.org/10.1007/s11538-022-01012-8
_version_ 1784683621263605760
author Wang, Xiunan
Wang, Hao
Ramazi, Pouria
Nah, Kyeongah
Lewis, Mark
author_facet Wang, Xiunan
Wang, Hao
Ramazi, Pouria
Nah, Kyeongah
Lewis, Mark
author_sort Wang, Xiunan
collection PubMed
description Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction power. Typically, a hypothesis is made on the form of the transmission rate with respect to time. Yet the real form is too complex to be mechanistically modeled due to the unknown dynamics of many influential factors. We tackle this problem by using a hypothesis-free machine-learning algorithm to estimate the transmission rate from data on non-pharmaceutical policies, and in turn forecast the confirmed cases using a mechanistic disease model. More specifically, we build a hybrid model consisting of a mechanistic ordinary differential equation (ODE) model and a gradient boosting model (GBM). To calibrate the parameters, we develop an “inverse method” that obtains the transmission rate inversely from the other variables in the ODE model and then feed it into the GBM to connect with the policy data. The resulting model forecasted the number of daily confirmed cases up to 35 days in the future in the USA with an averaged mean absolute percentage error of 27%. It can identify the most informative predictive variables, which can be helpful in designing improved forecasters as well as informing policymakers.
format Online
Article
Text
id pubmed-8991680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89916802022-04-11 A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies Wang, Xiunan Wang, Hao Ramazi, Pouria Nah, Kyeongah Lewis, Mark Bull Math Biol Original Article Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction power. Typically, a hypothesis is made on the form of the transmission rate with respect to time. Yet the real form is too complex to be mechanistically modeled due to the unknown dynamics of many influential factors. We tackle this problem by using a hypothesis-free machine-learning algorithm to estimate the transmission rate from data on non-pharmaceutical policies, and in turn forecast the confirmed cases using a mechanistic disease model. More specifically, we build a hybrid model consisting of a mechanistic ordinary differential equation (ODE) model and a gradient boosting model (GBM). To calibrate the parameters, we develop an “inverse method” that obtains the transmission rate inversely from the other variables in the ODE model and then feed it into the GBM to connect with the policy data. The resulting model forecasted the number of daily confirmed cases up to 35 days in the future in the USA with an averaged mean absolute percentage error of 27%. It can identify the most informative predictive variables, which can be helpful in designing improved forecasters as well as informing policymakers. Springer US 2022-04-08 2022 /pmc/articles/PMC8991680/ /pubmed/35394257 http://dx.doi.org/10.1007/s11538-022-01012-8 Text en © The Author(s), under exclusive licence to Society for Mathematical Biology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Wang, Xiunan
Wang, Hao
Ramazi, Pouria
Nah, Kyeongah
Lewis, Mark
A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title_full A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title_fullStr A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title_full_unstemmed A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title_short A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
title_sort hypothesis-free bridging of disease dynamics and non-pharmaceutical policies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991680/
https://www.ncbi.nlm.nih.gov/pubmed/35394257
http://dx.doi.org/10.1007/s11538-022-01012-8
work_keys_str_mv AT wangxiunan ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT wanghao ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT ramazipouria ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT nahkyeongah ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT lewismark ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT wangxiunan hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT wanghao hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT ramazipouria hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT nahkyeongah hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies
AT lewismark hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies